The Office of the Commissioner of Baseball announced today that Philadelphia Phillies Minor League infielder Pablo Ozuna has received a 50-game suspension after showing an elevated Testosterone/Epitestosterone ratio, a performance-enhancing substance violation of the Minor League Drug Prevention and Treatment Program.
Ozuna's suspension based upon elevated levels of Testosterone/Epitestosterone is a first at the minor league level this year. All other suspensions are for outright positive tests for a listed PED, substance of abuse, or for amphetimines, which is considered a performance-enhanciing drug
The suspension of Ozuna is effective immediately. Ozuna is currently a member of Triple-A Lehigh Valley of the International League.
Ozuna is the fifteenth minor league player suspended this season compared to seven last season at this time. When adding in players suspended under the Major League Drug Prevention and Treatment Program, the total number of players suspended in 2009 is 19.
See The Biz of Baseball's MLB and Minor League Drug Violations tracker, which details every drug suspension in baseball.
Maury Brown is the Founder and President of the Business of Sports Network, which includes The Biz of Baseball, The Biz of Football, The Biz of Basketball and The Biz of Hockey. He is contributor to Baseball Prospectus, and is available as a freelance writer. Brown's full bio is here. He looks forward to your comments via email and can be contacted through the Business of Sports Network.
Don't forget to register and log in on The Biz of Baseball site to get updates via your in-box, and see information only logged in members can see.
Follow Maury Brown and the Business of Sports Network on Twitter